Revolution Medicines, Inc. ( RVMD) - Key Metrics
RVMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$3.06 | -$3.52 | -$3.53 |
| 2026Q1 | $0 | -$2.29 | -$1.79 | -$1.80 |
| 2025Q4 | $0 | -$1.92 | -$1.44 | -$1.45 |
| 2025Q3 | $0 | -$1.61 | -$1.10 | -$1.11 |
| 2025Q2 | $0 | -$1.32 | -$1.18 | -$1.22 |
RVMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -15.30 |
| 2026Q1 | 0% | -10.62 |
| 2025Q4 | 0% | -10.48 |
| 2025Q3 | 0% | -7.25 |
| 2025Q2 | 0% | -7.02 |
RVMD
Price: $203.71
52 week price:
Earnings Per Share: -8.87 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 856800
Market Capitalization: 44.1 billion